Granules India Limited

The Granules India Limited was founded in year 1984. The company's pharmaceutical product focused with vertically integrated business model. It has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin. The company nearly 60% of revenue are from the US and Europe. Its key customers include some of the leading generic, as well as, branded pharmaceutical companies. It has integrated model for manufacturing APIs, PFIs and Finished Dosages enables us to provide products across the value chain and enhances its competitiveness. The company has emerged into a knowledge driven, R&D focused, multi-product organization, with inherent strength in efficient manufacturing of high-volume pharmaceutical products.